HELX vs IBB

Franklin Genomic Advancements ETF against iShares Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
26%
34 shared positions
Fee gap
6 bp
IBB is cheaper
1-year return gap
6.7 pts
IBB is ahead
Larger fund
IBB
$10.8B

Side by side

HELXIBB
FundFranklin Genomic Advancements ETFiShares Biotechnology ETF
IssuerFranklin TempletoniShares
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.50%0.44%
Assets$32M$10.8B
Average daily dollar volume$441K$343M
ListedFeb 25, 2020Feb 5, 2001
FrenzyCap score4283
1-month return+3.9%+1.9%
3-month return+7.3%+8.9%
Year to date+17.4%+22.4%
1-year return+29.2%+35.9%
30-day volatility28.2%23.0%
Worst drawdown, 1 year−18.0%−9.7%
Trailing 12-month yield0.34%0.17%
Holdings63248
Top 10 weight47.1%49.9%
Look-through P/E64596.3—
Holdings vs fair value−3.0%−0.0%
Holdings above 200-day average73%77%
Net flow, latest 3 reported months+$2.0M thru Jun 2026−$43M thru Jun 2026
30-day implied volatility37.1%24.1%
Holdings as ofas of Jun 30, 2026SEC filingas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

63% of HELX · 37% of IBB
HoldingHELXIBB
NTRA7.46%3.88%
VRTX2.75%7.70%
ALNY1.96%2.21%
REGN1.80%5.40%
UTHR3.51%1.63%
INSM2.44%1.59%
NBIX1.84%1.05%
CRL1.26%1.04%
MEDP2.15%1.00%
BBIO3.50%0.84%
TWST2.85%0.71%
BNTX1.38%0.65%
RGEN0.98%0.64%
KRYS6.33%0.63%
AXSM0.82%0.55%
TEM1.95%0.55%
IONS1.91%0.52%
PRAX0.86%0.51%
RYTM0.42%0.44%
GRAL1.09%0.41%
PTCT1.46%0.37%
TVTX2.59%0.35%
ADPT3.99%0.30%
VCYT1.64%0.25%
ONC0.23%2.17%

Sector mix of the stock holdings

SectorHELXIBBGap
Health Care80.2%95.1%−14.9%
Technology5.8%4.7%+1.0%
Consumer Staples2.3%0.0%+2.3%
Materials0.0%0.0%−0.0%

More: full overlap table · HELX holdings · IBB holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.